These events suggest that AID, through inflammation, could boost CHIP development resulting in the production of mutated lymphocytes that could eventually cause lymphoproliferative disorders but also that CHIP could be the “primum movens” of both the impaired immune function that leads to AID and lymphomagenesis (Figure 1). This evidence concerns the gene STUB1 and lymphoproliferative syndrome.